Clinical Indication ID & Name
Glycogen storage disease
Test Group
Metabolic
Test code
R274.1
Test name
N/A
Target genes
Glycogen storage disease (528)
Test scope
n/a
Test method/ technology
WES or Medium Panel
Optimal Family Structure
n/a
Eligibility Criteria
Clinical and laboratory features characteristic of Glycogen storage disease:
1. Persistent hypoglycaemia with other metabolic disorders excluded, AND one or more of the following
a. Persistent hepatomegaly in childhood, OR
b. Liver biopsy suggestive of glycogen storage disease, OR
c. Neuromuscular presentation suggestive of glycogen storage disease, OR
d. Affected first degree relative
OR
1. Glycogen accumulation in the relevant tissue, AND one or more of the following:
a. Evidence of liver involvement: hepatomegaly OR hypoglycaemia with other metabolic disorders excluded, OR
b. Evidence of muscle involvement: myalgia OR rhabdomyolysis OR muscle weakness, OR
c. Evidence of cardiac involvement: cardiomegaly OR cardiomyopathy, OR
d. Other general evidence – at least two of: myopathy, cardiomyopathy, respiratory weakness,
vacuolar myopathy on muscle biopsy, pathological pattern on oligosaccharides
Test code
R274.2
Test name
N/A
Target genes
Glycogen storage disease (528)
Test scope
n/a
Test method/ technology
Exon level CNV detection by MLPA or equivalent
Optimal Family Structure
n/a
Eligibility Criteria
Clinical and laboratory features characteristic of Glycogen storage disease:
1. Persistent hypoglycaemia with other metabolic disorders excluded, AND one or more of the following
a. Persistent hepatomegaly in childhood, OR
b. Liver biopsy suggestive of glycogen storage disease, OR
c. Neuromuscular presentation suggestive of glycogen storage disease, OR
d. Affected first degree relative
OR
1. Glycogen accumulation in the relevant tissue, AND one or more of the following:
a. Evidence of liver involvement: hepatomegaly OR hypoglycaemia with other metabolic disorders excluded, OR
b. Evidence of muscle involvement: myalgia OR rhabdomyolysis OR muscle weakness, OR
c. Evidence of cardiac involvement: cardiomegaly OR cardiomyopathy, OR
d. Other general evidence – at least two of: myopathy, cardiomyopathy, respiratory weakness,
vacuolar myopathy on muscle biopsy, pathological pattern on oligosaccharides
Commissioning group
Specialised
Overlapping idications
• R273 Glycogen storage disease V test should be considered where clinical features are specific to Glycogen storage disease V (McArdle disease) • It is anticipated that many specific metabolic diagnoses will be made through use of broad genomic testing via the R98 Likely inborn error of metabolism - targeted testing is not possible early in the investigative pathway and in cases with atypical features where a broader differential diagnosis is under consideration
Address for samples/request forms
North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH
Contact with queries
Supporting documents
Rare Disese WGS Clinician pack
Education resources
n/a
Service updates
n/a
Request form download
Consent record
See consent guidance in test request form
Sample requirements
See sample guidance in test request form